The technologies and their applications in the prevention and control of main porcine viral diarrhea

Jianfei Chen, Da Shi, Hongyan Shi, YouEn Tong, Xin Zhang, Li FengScientia 2023 · DOI

Abstract: Transmissible gastroenteritis (TGE), porcine epidemic diarrhea (PED) and porcine rotavirus infection (PoRVI) are three main swine viral diseases, which are highly contagious and characterized by clinical signs including vomiting, watery diarrhea, dehydration and high mortality in suckling piglets less than two-weeks old. These diseases are widespread in China with serious co-infection, which have caused huge economic losses to the pig industry. In the prevention and control of infectious diseases, vaccine is one of the most effective and economic means. In this article, the research history of these three major porcine viral diarrhea at home and abroad is reviewed, with a focus on the research progress of corresponding vaccines and related diagnostic technologies in China. We also analyze the key problems in the prevention and control of porcine viral diarrhea in China, and propose relevant strategies to solve these problems.

Introduction

Porcine viral diarrhea (PVD) remains a primary threat to the global swine industry, particularly affecting suckling piglets. In China, the landscape of PVD is dominated by three major pathogens: Transmissible Gastroenteritis Virus (TGEV), Porcine Epidemic Diarrhea Virus (PEDV), and Porcine Rotavirus (PoRV). These enteric viruses cause severe gastrointestinal distress, leading to mortality rates that can reach 100% in piglets under two weeks of age.

The challenge in China is uniquely complex due to the high prevalence of co-infections, where multiple viruses strike a single herd simultaneously. Furthermore, the rapid evolution of these viruses—most notably the emergence of highly virulent G2 variants of PEDV since 2010—has created a persistent "antigenic mismatch" between older vaccine strains and circulating field variants.

Vaccine Development and Multi-valency

To combat these pathogens, researchers at the Harbin Veterinary Research Institute (HVRI) and other institutions have focused on developing safe, live-attenuated vaccines (LAVs). This process involves adapting wild-type viruses to grow in specific cell lines, such as ST cells for TGEV and Vero cells for PEDV, until they lose their virulence while retaining their ability to stimulate an immune response.

Identification and characterization of attenuated viral strains (TGEV, PEDV, PoRVI) used in vaccine development.

A major breakthrough in Chinese veterinary medicine was the development of multi-valent vaccines. Rather than administering separate shots for each virus, researchers created a trivalent TGE-PED-PoRVI live vaccine. This "all-in-one" approach addresses the reality of co-infections in the field, simplifying vaccination schedules for farmers and providing broad-spectrum protection. Clinical trials have demonstrated that this trivalent vaccine achieves an active protection rate of 96.15% and a passive protection rate (transferred via sow's milk) of 88.7%.

Innovative Delivery: The Houhai Acupoint

Standard intramuscular injections often fail to provide adequate protection against enteric diseases because they do not sufficiently stimulate the gut's mucosal immune system. Success in PVD control depends on inducing secretory IgA (sIgA) in the intestinal mucosa of the piglet and in the colostrum of the sow.

China has pioneered a unique delivery method: Houhai point immunization. The Houhai point is an acupoint located in the depression between the anus and the tail root. Research indicates that injecting vaccines at this site better activates the mucosal immune system compared to oral or traditional muscle-based delivery.

Anatomical location of the Houhai acupoint, a critical site for inducing mucosal immunity in swine.

Early trials showed that for TGE, Houhai point injection provided approximately 60% protection, whereas oral delivery offered only 6%. Refined bivalent and trivalent vaccines delivered via this route have since achieved protection rates exceeding 95%, making it a cornerstone of PVD prevention strategy in China.

Diagnostic Advancements and Economic Impact

Effective control requires more than just vaccines; it requires precise diagnostics. Researchers have developed "Differentiating Infected from Vaccinated Animals" (DIVA) technologies. By identifying specific molecular markers—such as a 28-bp deletion unique to the PEDV CV777 vaccine strain—scientists can use RT-PCR assays to determine if a virus detected in a herd is a vaccine strain or a new field outbreak.

The economic impact of these technologies is substantial. HVRI-developed vaccines have been transferred to 24 biological companies, with over 60 million doses distributed. This has resulted in an estimated economic benefit of 500 million RMB, significantly stabilizing the domestic pig industry.

Future Directions

Despite these advancements, the continuous evolution of viruses like PEDV necessitates ongoing research. The next generation of PVD control will likely move toward more agile platforms, including mRNA vaccines, subunit vaccines, and viral vector systems that can be rapidly updated to match emerging variants. Additionally, the development of more potent mucosal adjuvants and a shift from mere "prevention" to "herd purification and eradication" represent the next frontiers in Chinese veterinary science.

Summary updated

Abstract

<p indent="0mm">Transmissible gastroenteritis (TGE), porcine epidemic diarrhea (PED) and porcine rotavirus infection (PoRVI) are three main swine viral diseases, which are highly contagious and characterized by clinical signs including vomiting, watery diarrhea, dehydration and high mortality in suckling piglets less than two-weeks old. These diseases are widespread in China with serious co-infection, which have caused huge economic losses to the pig industry. In the prevention and control of infectious diseases, vaccine is one of the most effective and economic means. In this article, the research history of these three major porcine viral diarrhea at home and abroad is reviewed, with a focus on the research progress of corresponding vaccines and related diagnostic technologies in China. We also analyze the key problems in the prevention and control of porcine viral diarrhea in China, and propose relevant strategies to solve these problems.
BibTeX
@inproceedings{chen2023technologies,
  author = {Jianfei Chen and Da Shi and Hongyan Shi and YouEn TONG and Xin ZHANG and Li Feng},
  title = {{The technologies and their applications in the prevention and control of main porcine viral diarrhea}},
  booktitle = {Scientia},
  year = {2023},
  doi = {10.1360/ssv-2023-0130},
}
Figure